Phase 1, multicentre, open-label, dose finding trial of forodesine in patients with relapsed B-cell chronic lymphocytic leukemia.
Phase of Trial: Phase I
Latest Information Update: 02 Apr 2010
At a glance
- Drugs Forodesine (Primary)
- Indications Chronic lymphocytic leukaemia
- Focus Therapeutic Use
- Sponsors Mundipharma International
- 02 Apr 2010 Planned end date changed from 1 Feb 2010 to 1 May 2009 as reported by ClinicalTrials.gov.
- 02 Apr 2010 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 05 Aug 2008 Actual start date has changed from Mar 2008 to Jul 2008 as reported by ClinicalTrials.gov.